Alterations of splenic architecture in malaria are induced independently of toll-like receptors 2, 4, and 9 or MyD88 and may affect antibody affinity

Infection and Immunity

Volumn 76, Issue 9, 2008, Pages 3924-3931

  Cadman, Emma T ^a,c   Abdallah, Asmahan Y ^a   Voisine, Cécile ^a   Sponaas, Anne Marit ^a   Corran, Patrick ^b   Lamb, Tracey ^a   Brown, Douglas ^a   Ndungu, Francis ^a   Langhorne, Jean ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^c ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; MYELOID DIFFERENTIATION FACTOR 88; PROTOZOAL VACCINE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY AFFINITY; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FEMALE; GERMINAL CENTER; IMMUNITY; IMMUNIZATION; MALARIA; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM CHABAUDI; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SPLEEN;

ANIMALS; ANTIBODY AFFINITY; FEMALE; MALARIA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; PARASITEMIA; PLASMODIUM CHABAUDI; SPLEEN; TOLL-LIKE RECEPTORS;

EID: 51949106699     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00372-08     Document Type: Article

References (71)

1. Achtman, A. H. 2003. The B cell response to Plasmodium chabaudi chabaudi malaria in the mouse model. Open University, London, United Kingdom.
2. Achtman, A. H., M. Khan, I. C. MacLennan, and J. Langhorne. 2003. Plasmodium chabaudi chabaudi infection in mice induces strong B cell responses and striking but temporary changes in splenic cell distribution. J. Immunol. 171:317-324.
3. Achtman, A. H., R. Stephens, E. T. Cadman, V. Harrison, and J. Langhorne. 2007. Malaria-specific antibody responses and parasite persistence after infection of mice with Plasmodium chabaudi chabaudi. Parasite Immunol. 29:435-444.
4. Adachi, K., H. Tsutsui, S. Kashiwamura, E. Seki, H. Nakano, O. Takeuchi, K. Takeda, K. Okumura, L. Van Kaer, H. Okamura, S. Akira, and K. Nakanishi. 2001. Plasmodium berghei infection in mice induces liver injury by an IL-12- and Toll-like receptor/myeloid differentiation factor 88-dependent mechanism. J. Immunol. 167:5928-5934.
5. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, and S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9:143-150.
6. Allen, C. D., K. M. Ansel, C. Low, R. Lesley, H. Tamamura, N. Fujii, and J. G. Cyster. 2004. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat. Immunol. 5:943-952.
7. Allen, C. D., T. Okada, and J. G. Cyster. 2007. Germinal-center organization and cellular dynamics. Immunity 27:190-202.
8. Alves, H. J., W. Weidanz, and L. Weiss. 1996. The spleen in murine Plasmodium chabaudi adami malaria: stromal cells, T lymphocytes, and hematopoiesis. Am. J. Trop. Med. Hyg. 55:370-378.
9. + T lymphocyte-mediated loss of marginal metallophilic macrophages following infection with Plasmodium chabaudi chabaudi AS. J. Immunol. 177:2518-2526.
10. Bejon, P., J. Mwacharo, O. Kai, S. Todryk, S. Keating, B. Lowe, T. Lang, T. W. Mwangi, S. C. Gilbert, N. Peshu, K. Marsh, and A. V. Hill. 2007. The induction and persistence of T cell IFN-γ responses after vaccination or natural exposure is suppressed by Plasmodium falciparum. J. Immunol. 179: 4193-4201.
11. Benedict, C. A., C. De Trez, K. Schneider, S. Ha, G. Patterson, and C. F. Ware. 2006. Specific remodeling of splenic architecture by cytomegalovirus. PLoS Pathog. 2:e16.
12. Carvalho, L. J., M. F. Ferreira-da-Cruz. C. T. Daniel-Ribeiro, M. Pelajo-Machado, and H. L. Lenzi. 2007. Germinal center architecture disturbance during Plasmodium berghei ANKA infection in CBA mice. Malaria J. 6:59.
13. Cohan, C., K. J. Ishii, T. Kawai, H. Hemmi, S. Sato, S. Uematsu, M. Yamamoto, O. Takeuchi, S. Itagaki, N. Kumar, T. Horii, and S. Akira. 2005. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J. Exp. Med. 201:19-25.
14. Crane, G. G., and D. S. Pryor. 1971. Malaria and the tropical splenomegaly syndrome in New Guinea. Trans. R. Soc. Trop. Med. Hyg. 65:315-324.
15. Dorfman, J. R., P. Bejon, F. M. Ndungu, J. Langhorne, M. M. Kortok, B. S. Lowe, T. W. Mwangi, T. N. Williams, and K. Marsh. 2005. B cell memory to 3 Plasmodium falciparum blood-stage antigens in a malaria-endemic area. J. Infect. Dis. 191:1623-1630.
16. Elliott, S. R., T. P. Spurck, J. M. Dodin, A. G. Maier, T. S. Voss, F. Yosaatmadja, P. D. Payne, G. I. McFadden, A. F. Cowman, S. J. Rogersou, L. Schofield, and G. V. Brown. 2007. Inhibition of dendritic cell maturation by malaria is dose dependent and does not require Plasmodium falciparum erythrocyte membrane protein 1. Infect. Immun. 75:3621-3632.
17. Engwerda, C. R., M. Ato, S. E. Cotterell, T. L. Mynott, A. Tschannerl, P. M. Gorak-Stolinska, and P. M. Kaye. 2002. A role for tumor necrosis factor-alpha in remodeling the splenic marginal zone during Leishmania donovani infection. Am. J. Pathol. 161:429-437.
18. Franklin, B. S., S. O. Rodrigues, L. R. Antonelli, R. V. Oliveira, A. M. Goncalves, P. A. Sales-Junior, E. P. Valente, J. I. Alvarez-Leite, C. Ropert, D. T. Golenbock, and R. T. Gazzineili. 2007. MyD88-dependent activation of dendritic cells and CTJ4+ T lymphocytes mediates symptoms, but is not required for the immunological control of parasites during rodent malaria. Microbes Infect. 9:881-890.
19. Groeneveld, P. H., T. Erich, and G. Kraal. 1986. The differential effects of bacterial lipopolysaccharide (LPS) on splenic non-lymphoid cells demonstrated by monoclonal antibodies. Immunology 58:285-290.
20. Grun, J. L., C. A. Long, and W. P. Weidanz. 1985. Effects of splenectomy on antibody-independent immunity to Plasmodium chabaudi adami malaria. Infect. Immun. 48:853-858.
21. Guo, F., D. Weih, E. Meier, and F. Weih. 2007. Constitutive alternative NF-κB signaling promotes marginal zone B-cell development but disrupts the marginal sinus and induces HEV-like structures in the spleen. Blood 110:2381-2389.
22. Helmby, H., G. Jonsson, and M. Troye-Blomberg. 2000. Cellular changes and apoptosis in the spleens and peripheral blood of mice infected with blood-stage Plasmodium chabaudi chabaudi AS. Infect. Immun. 68:1485-1490.
23. Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, and S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740-745.
24. Hoshino, K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, and S. Akira. 1999. Cutting edge. Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162:3749-3752.
25. lizuka, T., T. Tanaka, M. Suematsu, S. Miura, T. Watanabe, R. Koike, Y. Ishimura, H. Ishii, N. Miyasaka, and M. Miyasaka. 2000. Stage-specific expression of mucosal addressin cell adhesion molecule-1 during embryogenesis in rats. J. Immunol. 164:2463-2471.
26. Janssens, S., and R. Bevaert. 2002. A universal role for MyD88 in TLR/ IL-1R-mediated signaling. Trends Biochem. Sci. 27:474-482.
27. Kraal, G., K. Schornagel, P. R. Streeter, B. Holzmann, and E. C. Butcher. 1995. Expression of the mucosal vascular addressin, MAdCAM-1, on sinuslining cells in the spleen. Am. J. Pathol. 147:763-771.
28. Krishnegowda, G., A. M. Hajjar, J. Zhu, E. J. Douglass, S. Uematsu, S. Akira, A. S. Woods, and D. C. Gowda. 2005. Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J. Biol. Chem. 280: 8606-8616.
29. Krucken, J., L. I. Mehnert, M. A. Dkhil, M. El-Khadragy, W. P. Benten, H. Mossmann, and F. Wunderlich. 2005. Massive destruction of malaria-parasitized red blood cells despite spleen closure. Infect. Immun. 73:6390-6398.
30. + T cells and malarial spleen in immunity to Plasmodium vinckei vinckei. Relevance to vaccine development. J. Immunol. 143:2017-2023.
31. + T cells reactive with Plasmodium chabaudi chabaudi: distinct response kinetics for cells with Th1 and Th2 characteristics during infection. Int. Immunol. 1:416-424.
32. Leisewitz, A. L., K. A. Rockett, B. Gumede, M. Jones, B. Urban, and D. P. Kwiatkowski. 2004. Response of the splenic dendritic cell population to malaria infection. Infect. Immun. 72:4233-4239.
33. MacLennan, I. C. 1994. Germinal centers. Annu. Rev. Immunol. 12:117-139.
34. Martin, F., and J. F. Kearney. 2002. Marginal-zone B cells. Nat. Rev. 2:323-335.
35. Martin-Peprah, R., I. Bates, G. Bedu-Addo, and D. P. Kwiatkowski. 2006. Investigation of familial segregation of hyperreactive malarial splenomegaly in Kumasi, Ghana. Trans. R. Soc. Trop. Med. Hyg. 100:68-73.
36. Meding, S. J., S. C. Cheng, B. Simon-Haarhaus, and J. Langhorne. 1990. Role of gamma interferon during infection with Plasmodium chabaudi chabaudi. Infect. Immun. 58:3671-3678.
37. Millington, O. R., C. Di Lorenzo, R. S. Phillips, P. Garside, and J. M. Brewer. 2006. Suppression of adaptive immunity to heterologous antigens during Plasmodium infection through hemozoin-induced failure of dendritic cell function. J. Biol. 5:5.
38. Millington, O. R., V. B. Gibson, C. M. Rush, B. H. Zinselmeyer. R. S. Phillips, P. Garside, and J. M. Brewer. 2007. Malaria impairs T cell clustering and immune priming despite normal signal 1 from dendritic cells. PLoS Pathog. 3:1380-1387.
39. Moser, K., G. Muehlinghaus, R. Manz, H. Mei, C. Voigt, T. Yoshida, T. Dorner, F. Hiepe, and A. Radbruch. 2006. Long-lived plasma cells in immunity and immunopathology. Immunol. Lett. 103:83-85.
40. Moser, K., K. Tokoyoda, A. Radbruch, I. MacLennan, and R. A. Manz. 2006. Stromal niches, plasma cell differentiation and survival. Curr. Opin. Immunol. 18:265-270.
41. Nogueira, P. A., F. P. Alves, C. Fernandez-Becerra, O. Pein, N. R. Santas, L. H. Pereira da Silva, E. P. Camargo, and H. A. del Portillo. 2006. A reduced risk of infection with Plasmodium vivax and clinical protection against malaria are associated with antibodies against the N terminus but not the C terminus of merozoite surface protein 1. Infect. Immun. 74:2726-2733.
42. Ocana-Morgner, C., M. M. Mota, and A. Rodriguez. 2003. Malaria blood stage suppression of liver stage immunity by dendritic cells. J. Exp. Med. 197:143-151.
43. Parker, L. C., M. K. Whyte, S. N. Vogel, S. K. Dower, and I. Sabroe. 2004. Toll-like receptor (TLR)2 and TLR4 agonists regulate CCR expression in human monocytic cells. J. Immunol. 172:4977-4986.
44. Parroche, P., F. N. Lauw, N. Goutagny, E. Latz, B. G. Monks, A. Visintin, K. A. Halmen, M. Lamphier, M. Olivier, D. C. Bartholomeu, R. T. Gazzinelli, and D. T. Golenbock. 2007. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc. Natl. Acad. Sci. USA 104:1919-1924.
45. Pichyangkul, S., K. Yongvanitchit, U. Kum-arb, H. Hemmi, S. Akira, A. M. Krieg, D. G. Heppner, V. A. Stewart, H. Hasegawa, S. Looareesuwan, G. D. Shanks, and R. S. Miller. 2004. Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway. J. Immunol. 172:4926-4933.
46. Pitney, W. R. 1968. The tropical splenomegaly syndrome. Trans. R. Soc. Trop. Med. Hyg. 62:717-728.
47. Pullen, G. R., M. G. Fitzgerald, and C. S. Hosking. 1986. Antibody avidity determination by ELISA using thiocyanate elution. J. Immunol. Methods 86:83-87.
48. Rockett, K. A., M. M. Awburn, E. J. Rockett, W. B. Cowden, and I. A. Clark. 1994. Possible role of nitric oxide in malarial immunosuppression. Parasite Immunol. 16:243-249.
49. Shaykhiev, R., J. Behr, and R. Bals. 2008. Microbial patterns signaling via Toll-like receptors 2 and 5 contribute to epithelial repair, growth and survival. PLoS ONE 3:e1393.
50. Sikorski, E. E., R. Hallmann, E. L. Berg, and E. C. Butcher. 1993. The Peyer's patch high endothelial receptor for lymphocytes, the mucosal vascular addressin, is induced on a murine endothelial cell line by tumor necrosis factor-alpha and IL-1. J. Immunol. 151:5239-5250.
51. Spahn, T. W., H. P. Eugster, A. Fontana, W. Domschke, and T. Kucharzik. 2005. Role of lymphotoxin in experimental models of infectious diseases: potential benefits and risks of a therapeutic inhibition of the lymphotoxin-beta receptor pathway. Infect. Immun. 73:7077-7088.
52. Steiniger, B., and P. Barth. 2000. Microanatomy and function of the spleen. Springer, Berlin, Germany.
53. + T cells protect immunodeficient mice from lethal infection and demonstrate requirement for a protective threshold of antibody production for parasite clearance. Blood 106:1676-1684.
54. Stevenson, M. M., and G. Kraal. 1989. Histological changes in the spleen and liver of C57BL/6 and A/J. mice during Plasmodium chabaudi AS infection. Exp. Mol. Pathol. 51:80-95.
55. Takeda, K., and S. Akira. 2004. TLR signaling pathways. Semin. Immunol. 16:3-9.
56. Takeuchi, O., and S. Akira. 2002. MyD88 as a bottle neck in Toll/IL-1 signaling. Curr. Top. Microbiol. Immunol. 270:155-167.
57. Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, and S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11:443-451.
58. Takeuchi, O., T. Kawai, P. F. Muhlradt, M. Morr, J. D. Radolf, A. Zychlinsky, K. Takeda, and S. Akira. 2001. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 13:933-940.
59. Tedder, T. F., D. A. Steeber, A. Chen, and P. Engel. 1995. The selectins: vascular adhesion molecules. FASEB J. 9:866-873.
60. Togbe, D., L. Schofleld, G. E. Grau, B. Schnyder, V. Boissay, S. Charron, S. Rose, B. Beutler, V. F. Quesniaux, and B. Ryffel. 2007. Murine cerebral malaria development is independent of Toll-like receptor signaling. Am. J. Pathol. 170:1640-1648.
61. Tsubata, S., K. Ebe, T. Kawamura, Y. Ishimoto, C. Tomiyama-Miyaji, H. Watanabe, H. Sekikawa, Y. Aoyagi, and T. Abo. 2005. Protection against malaria by anti-erythropoietin antibody due to suppression of erythropoiesis in the liver and at other sites. Immunol. Cell Biol. 83:638-642.
62. Tumanov, A. V., S. I. Grivennikov, A. N. Shakhov, S. A. Rybtsov, E. P. Koroleva, J. Takeda, S. A. Nedospasov, and D. V. Kuprash. 2003. Dissecting the role of lymphotoxin in lymphoid organs by conditional targeting. Immunol. Rev. 195:106-116.
63. Unkeless, J. C. 1979. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J. Exp. Med. 150: 580-596.
64. Urban, B. C., D. J. Ferguson, A. Pain, N. Willcox, M. Plebanski, J. M. Austyn, and D. J. Roberts. 1999. Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells. Nature 400:73-77.
65. Urban, B. C., T. T. Hien, N. P. Day, N. H. Phu, R. Roberts, E. Pongponratn, M. Jones, N. T. Mai, D. Bethell, G. D. Turner, D. Ferguson, N. J. White, and D. J. Roberts. 2005. Fatal Plasmodium falciparum malaria causes specific patterns of splenic architectural disorganization. Infect. Immun. 73:1986-1994.
66. Walliker, D., R. Carter, and A. Sanderson. 1975. Genetic studies on Plasmodium chabaudi: recombination between enzyme markers. Parasitology 70:19-24.
67. Weiss, L. 1989. Mechanisms of splenic control of murine malaria: cellular reactions of the spleen in lethal (strain 17XL) Plasmodium yoelii malaria in BALB/c mice, and the consequences of pre-infective splenectomy. Am. J. Trop. Med. Hyg. 41:144-160.
68. Weiss, L., J. Johnson, and W. Weidanz. 1989. Mechanisms of splenic control of murine malaria: tissue culture studies of the erythropoietic interplay of spleen, bone marrow, and blood in lethal (strain 17XL) Plasmodium yoelii malaria in BALB/c mice. Am. J. Trop. Med. Hyg. 41:135-143.
69. Wilson, N. S., G. M. Behrens, R. J. Lundie, C. M. Smith, J. Waithman, L. Young, S. P. Forehan, A. Mount, R. J. Steptoe, K. D. Shortman, T. F. de Koning-Ward, G. T. Belz, F. R. Carbone, B. S. Crabb, W. R. Heath, and J. A. Villadangos. 2006. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat. Immunol. 7:165-172.
70. Wykes, M. N., X. Q. Liu, S. Jiang, C. Hininpetcharat, and M. F. Good. 2007. Systemic tumor necrosis factor generated during lethal Plasmodium infections impairs dendritic cell function. J. Immunol. 179:3982-3987.
71. Wykes, M. N, Y. H. Zhou, X. Q. Liu, and M. F. Good. 2005. Plasmodium yoelii can ablate vaccine-induced long-term protection in mice. J. Immunol. 175:2510-2516.